The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, first-in-human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors.
 
Kim Anna Reiss
Honoraria - MJH Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Tesaro (Inst)
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech; Immunomedics; Merck; Novartis; Pfizer
Research Funding - Eisai; Genentech; Merck; Novartis; Pfizer; Puma Biotechnology
Expert Testimony - Novartis
 
Debora Barton
Employment - Advanced Accelerator Applications; Carisma Therapeutics; Iovance Biotherapeutics
Stock and Other Ownership Interests - Advanced Accelerator Applications; Carisma Therapeutics; Iovance Biotherapeutics
 
Daniel Cushing
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Amy Ronczka
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Michael Klichinsky
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Elizabeth Claire Dees
Consulting or Advisory Role - G1 Therapeutics; Novartis (I); Strata Oncology
Research Funding - Genentech/Roche; H3 Biomedicine; Merck; Meryx Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - G1 Therapeutics